Lysoway Therapeutics

Cambridge, United States

Lysoway Therapeutics has developed technological methods to screen and develop potent modulators of lysosomal ion channels.

$3.4M raised

Jun 2026

Grant

Biotechnology Medical Device Therapeutics

Top Investors

Michael J. Fox Foundation The Silverstein Foundation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lysoway Therapeutics

How much funding has Lysoway Therapeutics raised?

Lysoway Therapeutics has raised $3.4M in total funding. The most recent round was Grant. The last funding was announced in June 2026.

Who are Lysoway Therapeutics's investors?

Lysoway Therapeutics's investors include Michael J. Fox Foundation, The Silverstein Foundation.

Where is Lysoway Therapeutics headquartered?

Lysoway Therapeutics is headquartered in Cambridge, United States.

What does Lysoway Therapeutics do?

Lysoway Therapeutics has developed technological methods to screen and develop potent modulators of lysosomal ion channels.

What stage is Lysoway Therapeutics at?

Lysoway Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 1, 2026.

MLA

"Lysoway Therapeutics — Funding & Investors." VCBacked, June 1, 2026, https://www.vcbacked.co/company/lysoway-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Lysoway Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lysoway-therapeutics

Wikipedia (cite web)

{{cite web |title=Lysoway Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lysoway-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 1, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K